Skip to main content

Table 1 Patient characteristics

From: Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients

  All patients
n = 144
Non-sepsis
n = 44
Sepsis
n = 100
p value
Sex (male/female) 88/56 27/17 61/39 ns
Age, years (mean ± SD) 58 ± 17.5 57.5 ± 20.1 58.3 ± 16 0.907
SAPS II, median (IQR) 47 (33–62) 44 (27–60) 48 (36–64) 0.176
SOFA, median (IQR) 8 (6–11) 6 (4–10) 8 (6–11) 0.008
Creatininemia, median (IQR), (μmol/L) 68 (27–102) 80 (29–107) 57 (26–101) 0.419
hsCRP, median (IQR), (mg/L) 108 (38–133) 31 (5–87) 180 (81–284) <0.0001
PCT, median (IQR), (ng/mL) 1.89 (0.32–13.7) 0.3 (0.1–0.9) 4.7 (0.8–20.5) <0.0001
Presepsin, median (IQR), (pg/mL) 1058 (510–2090) 454 (315–915) 1432 (773–2337) <0.0001
ICU length of stay (IQR), (days) 4 (2–10) 3 (1–7) 5 (2–11) 0.04
ICU mortality, n (%) 34 (23.6) 9 (20.4) 25 (25) ns
In-hospital mortality, n (%) 38 (26.3) 10 (22.7) 28 (28) ns
  1. Comparison between septic and non-septic patients
  2. SAPS simplified acute physiology score, SOFA sequential organ failure assessment score, PCT procalcitonin, hsCRP high-sensitivity C-reactive protein
  3. p: differences between septic and non-septic patients